Just had a look at these links. Sam Wright was around back then, so he would be the best person to chat with re this. He and Bryant both come from equities backgrounds, not pharma. It looks like they were trying to add to Epichem's business by way of diversification, but O&G seems an odd fit? Then maybe they finally found Pitney as a better option.
Other guess is that they wanted to acquire the O&G assets to later spin-off into different entities? This would be messy along side a pharma company, but still cheaper than doing an RTO??
Just had a look at these links. Sam Wright was around back then,...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.005(2.78%) |
Mkt cap ! $89.95M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 19.0¢ | 18.5¢ | $111.6K | 601.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 169572 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 613756 | 10 |
View Market Depth
| Last trade - 15.46pm 30/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |